PropertyValue
?:definition
  • Immunoassay reagents intended to perform quantitative analyses on a body fluid sample (e.g., serum, plasma) to measure levels of procainamide (an antiarrhythmic drug used in the treatment of premature ventricular contractions [PVCs], ventricular tachycardia, and atrial fibrillation) in a sample. These reagents are used in tests to monitor procainamide levels in patients undergoing treatment to determine the adequacy of therapy and to diagnose drug overdose or drug-related toxicity. Procainamide levels are typically measured in conjunction with levels of the procainamide metabolite, N-acetylprocainamide (NAPA).
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3690690_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3690690_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all